BTT Group

[Building Towards Tomorrow] Through the vision of "Building Towards Tomorrow," we connect today's achievements with tomorrow's innovations, striving tirelessly to realize our clients' goals in the drug development journey. Our core values play a vital role in actualizing this vision and building a better future together with our clients. [BTT Group’s Solutions] From the early stages of development, we systematically organize and structure preclinical components based on material composition and design, helping reduce costs and increase the likelihood of success, thus efficiently supporting our clients' drug development process. 1. Preclinical Research and GLP Studies * IND/NDA-supporting toxicology studies meeting FDA, EMA, and - global regulatory standards. - Safety Evaluation - Safety Pharmacology - General Toxicity - Complement Split Product Analysis - Neurobehavioral Testing - Intra-Vitreous * Customized study designs to evaluate pharmacology and efficacy. - Efficacy Evaluation 2. Advanced Bioanalysis * Quantitative analysis of therapeutic distribution in specific tissues and organs. - Biodistribution * Precise biological sample analysis using LC-MS/MS, ELISA, and ECL technologies. - ADME & Bioanalysis 3. Specialized Non-Human Primate (NHP) Studies * Comprehensive safety and pharmacology research using NHPs in state-of-the-art facilities. - NHP Safety - NHP Pharmacology - Inhalation Toxicity 4. Integrated Project Management * Dedicated teams ensure seamless communication, risk management, and efficient project execution. * Customized solutions to meet clients' goals and regulatory requirements. * SEND-compliant data management to ensure accuracy and regulatory adherence. For more information, please visit our website!